Meeta Chatterjee

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jonathan Owen, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Meeta Chatterjee:

Company Role Class Num Shares Value Price $ Report Date Ownership
Werewolf Therapeutics, Inc. Director Stock Option (right to buy) 27,000 12 Jun 2025 Direct
Editas Medicine, Inc. Director Stock Option (right to buy) 25,000 30 May 2024 Direct

Insider Reports Filed by Meeta Chatterjee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOWL Werewolf Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:10
EDIT Editas Medicine, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 17:13
HOWL Werewolf Therapeutics, Inc. 24 May 2024 1 $0 4 Director 24 May 2024, 19:46
HOWL Werewolf Therapeutics, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:49
EDIT Editas Medicine, Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 16:30
EDIT Editas Medicine, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:30
HOWL Werewolf Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:39
HOWL Werewolf Therapeutics, Inc. 28 Oct 2021 1 $0 4 Director 01 Nov 2021, 16:12
HOWL Werewolf Therapeutics, Inc. 28 Oct 2021 0 $0 3 Director 01 Nov 2021, 16:11
EDIT Editas Medicine, Inc. 03 Jun 2021 1 $0 4 Director 07 Jun 2021, 16:13